However, it is important to understand that these medications do not selectively target belly fat they promote generalised fat loss throughout the body, with abdominal fat reduction occurring as part of this overall process
Data set was divided into training set and test set by use of 80%/20% training/test split ratio
Syngo AX software (Siemens Medical Solutions, AX, Berlin, Munich) was utilized for image acquisition and analysis
Dihexa crosses the blood-brain barrier and demonstrates oral bioavailability, properties that are rare among cognitive-enhancing peptides
Compounded medications are not FDA-approved and do not undergo FDA review for safety, effectiveness, or manufacturing quality
When it is "downregulated," it becomes less active